EthicsCase10-12onpage553-MayerBiotechnical,Inc-Researchanddevelopment®LO8MayerBiotechnical,Inc.,develops,manufactures,andsellspharmaceuticals.Significantresearchanddevelopment(R&D)expendituresaremadeforthedevelopmentofnewdrugsandtheimprovementofexistingdrugs.During2011,$220millionwasspentonR&D.Ofthisamount,$30millionwasspentonthepurchaseofequipmenttobeusedinaresearchprojectinvolvingthedevelopmentofanewantibiotic.Thecontroller,AliceCooper,isconsideringcapitalizingtheequipmentanddepreciatingitoverthefive-yearusefullifeoftheequipmentat$6millionperyear,eventhoughtheequipmentlikelywillbeusedononlyoneproject.ThecompanypresidenthasaskedAlicetomakeeveryefforttoincrease2011earningsbecausein2012thecompanywillbeseekingsignificantnewfinancingfrombothdebtandequitysources.“Iguesswemightusetheequipmentinotherprojectslater,”Alicewonderedtoherself.Required:1.Assumingthattheequipmentwaspurchasedatthebeginningof2011,byhowmuchwouldAlice’streatmentoftheequipmentincreasebeforetaxearningsasopposedtoexpensingtheequipmentcost?2.DiscusstheethicaldilemmaAlicefacesindeterminingthetreatmentofthe$30millionequipmentpurchase.I~StudyXYEthics Case 10-12 Mayer Biotechnical, Inc - Research and Development
A case study solution evaluating ethical concerns in research and development at Mayer Biotechnical, Inc.
Elizabeth Chen
Contributor
4.6
0
over 1 year ago
Preview (2 of 1 Pages)
100%
Log in to unlock
Study Now!
X-Copilot AI
Unlimited Access
Secure Payment
Instant Access
24/7 Support
Document Chat
Document Details
Subject
Business Management